1Gratwohl A, Passweg J, Baldomero H, et al. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation ( EBMT ). Bone Marrow Transplant,1999, 24(3) : 231-245.
2Padovan CS, Yousry TA, Schleuning M. Neurological and neuro-radiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol, 1998, 43 (5) : 627-633.
3Uckan D, Cetin M, Yigitkanli I, et al. Life-threatening neurological complications after bone marrow transplantation in children.Bone Marrow Transplant, 2005, 35 ( 1 ) : 71-76.
4Padovan CS, Bise K, Hahn J, et al. Angiitis of the Central Nervous System After Allogeneic Bone Marrow Transplantation.Stroke, 1999, 30(8): 1651-1656.
6Flowers ME, Kansu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am,1999, 13(5): 1091-1112.
7Vogelsang GB, Wagner JE. Graft versus host disease. Hematol Oneol Clin North Am, 1990, 4(3): 625-640.
8Jacobson DL, Gange S J, Rose NR, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol, 1997, 84 (3) : 223-243.
9Medsger TA Jr, Dawson WN Jr, Masi AT. The epidemiology of polymyositis. Am J Med, 1970, 48(6): 715-723.
10Oddis CV, Conte CG, Steen VD, et al. Incidence of polymyositis-dermatomyositis : a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol, 1990, 17(10): 1329-1334.
